+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID05456256

Phase II Study of LP-300 With Carboplatin and Pemetrexed in Adults Who Have Never Smoked and Have Advanced Lung Adenocarcinoma After Tyrosine Kinase Inhibitor Treatment

Led by Lantern Pharma Inc. · Updated on 2026-05-04

90

Participants Needed

16

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the clinical benefits of adding LP-300 to the standard chemotherapy drugs carboplatin and pemetrexed for patients who have never smoked and have advanced lung adenocarcinoma that has returned after treatment with tyrosine kinase inhibitors. This phase II, multicenter, open-label trial aims to measure progression-free survival and overall survival in this specific patient group. The trial includes two stages a safety lead-in with 6 patients receiving LP-300 combined with carboplatin and pemetrexed, followed by a randomized stage where patients will be assigned in a 21 ratio to either receive LP-300 plus carboplatin and pemetrexed or carboplatin and pemetrexed alone. Treatments are given intravenously on Day 1 of each 21-day cycle, with 4 to 6 cycles planned based on physician discretion. After these cycles, patients may continue with pemetrexed maintenance therapy if appropriate. Participants will undergo regular assessments including scans to measure tumor response, laboratory tests to monitor blood and organ function, and safety evaluations throughout the study. Researchers will track progression-free survival and overall survival for about two years, along with secondary outcomes like response rates and treatment safety. The total duration of participation depends on treatment cycles and follow-up, with close monitoring for any side effects or clinical changes.

CONDITIONS

Brief Title

A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

Research Team

S

Sandra Sinclair

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here